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Abstract 
Hypoplastic left heart syndrome (HLHS) is a rare congenital heart defect, occurring in 2-3 
infants per 10,000 births.  These patients have a high mortality rate of about 40% within the first 
year of life, with death occurring between sequential, palliative surgeries in the newborn period. 
Recently, infants with HLHS have also been identified with T cell lymphopenia (TCL) by 
newborn screening for severe combined immunodeficiency; however, the incidence and impact 
of lymphopenia in newborns with HLHS is unknown.  Following referral of an infant with HLHS, 
recurrent infections and T cell lymphopenia, we noted numerous iatrogenic causes for 
lymphopenia in the inter-surgical period. To determine the frequency of lymphopenia in infants 
with HLHS at our institution, we performed a retrospective review of patients evaluated between 
2008 and 2014.  Sixty-eight infants with HLHS were included, 44 of them had absolute 
lymphocyte counts (ALC) done in the inter-surgical period (0.7-1.9 months of age).  Inter-
surgical lymphopenia (34.1%) was far more frequent than pre-surgical lymphopenia (5.3%) (p= 
0.0003). Several risk factors were found to be associated with inter-surgical lymphopenia, 
including chylous leak (p=0.01) and hydrocortisone stress dose (p=0.03).  Lymphopenia was 
found to be associated with an increased risk for mortality (OR 4.36, CI 1.1-17.0, p=0.03) and a 
higher number of post-operative infections (OR 11.74, CI 1.9-71.0, p=0.01).   Further on, ALC 
was found to be inversely correlated with superior vena cava pressure, suggesting that the 
association between lymphopenia and poor postoperative outcomes may be modulated by the 
severity of cardiac disease.  These results suggest that inter-surgical lymphopenia in infants 
with HLHS is a marker for adverse postoperative outcomes during the first year of life.  
 
 
 
iii 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
Acknowledgement:  
This research was supported by NIH, 2T32AI060515-11. I would like to express my sincere 
gratitude to my thesis committee: Erin Haynes, PhD, Chesney Castleberry, MD, MB Rao, PhD, 
and Kimberly Risma MD/PhD for their insightful comments that greatly improve the manuscript, 
their encouragement and for sharing their pearls of wisdom with me. I would also like to thank 
CCHMC Biomedical Informatics Department for the assistance with the data collection and 
Michael Eby and Pablo Abonia, MD for the assistance with data management and insightful 
comments. 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
Table of Contents 
Abstract     ii 
Introduction   1 
Methods   1 
Results   5 
Discussion   13 
Conclusion   20 
References   21 
Tables    24 
Figures   28 
Supplementary Tables 33 
Supplementary Figures  36 
 
 
 
 
 
 
 
 
 
 
vi 
 
Table List  
I. Baseline Characteristics of Infants with HLHS: Categorical Data  
II. Risk Factors for Inter-Surgical Lymphopenia 
III. Risk Factors for Mortality, Postoperative Infections and Prolonged Hospital Stay after 
Glenn 
IV. ALC from Infants with available TREC results 
Figure List  
1.  Immune Laboratory results and ALC of an infant with HLHS and recurrent infections 
2. Cohort of Infants with HLHS evaluated for lymphopenia during the inter-surgical period 
(0.7-1.9 months) 
3. Lymphopenia, but not neutropenia, is associated with mortality and post-operative 
infections  
4. Survival of Infants according to lymphopenia status 
5. Association of poor cardiac function with ALC, mortality and postoperative infections 
Supplementary Table List  
I. Calculated rate of TCL in infants with and without HLHS  
II. Baseline Characteristics of Infants with HLHS: Numerical Data  
III. Immune results in the early inter-surgical period 
Supplementary Figure List  
1.  Cohort of patients with HLHS evaluated at CCHMC 
2. Outcome of Infans with pre-surgical lymphopenia  
3. Etiology of Post-operative Infections 
1 
 
Introduction 
Infants presenting with hypoplastic left heart syndrome (HLHS) have a mortality chance of 32-
48% in the first year of life [1-4], and factors leading to death are not completely understood. 
Recent studies have identified infants with HLHS presenting with T cell lymphopenia (TCL) 
during the neonatal screening [5-7].  However, the prevalence of lymphopenia in infants with 
HLHS is unknown and there is no information regarding its clinical significance. 
We evaluated an infant with HLHS presenting with recurrent infections and severe TCL. Review 
of the chart showed that there were many factors that may have contributed to development of 
lymphopenia, including high dose steroid administration and iatrogenic thymectomy during early 
palliative cardiac repair.  
To determine if these findings were generalizable to others with HLHS, we performed a 
retrospective review of infants with HLHS at our institution between 2008 and 2014.  Given that 
the majority of the infants did not have documented T cell counts, absolute lymphocyte counts 
(ALC) were used as a surrogate to assess lymphopenia. We evaluated 1) the proportion of 
lymphopenia before and after first palliative surgery 2) associated risk factors for developing 
inter-surgical lymphopenia and 3) associated morbidities (hospital length of stay, postoperative 
infections and mortality).  We determined that secondary lymphopenia is more common than 
primary lymphopenia in infants with HLHS and is associated with adverse postoperative 
outcomes.  
Methods 
Study Design 
A retrospective review of infants with HLHS evaluated at CCHMC from January 1, 2008 to 
August 31, 2014 was performed.  Infants with HLHS were identified using ICD9 codes for HLHS 
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and cross referenced with the cardiothoracic surgical database.  Patients without information 
about cardiac evaluations or cardiac surgeries were excluded from the study.  Infants without 
ALC during the first 4 months of life were also excluded.  Infants without corrective surgery or 
thymectomy during the first 30 days of life or having other surgeries rather than the first 
palliative surgeries for HLHS (Norwood or Hybrid) were also excluded from the study to 
decrease any confounder factors. The study was approved by CCHMC IRB. 
Definition of Lymphopenia  
For all infants, multiple lymphocyte counts were available. Pre-surgical lymphopenia was 
defined as the first available ALC before surgery, being less than 2,000 cells/mcl (below lower 
limit of 95% CI for patients less than 1 month old). ALC was also evaluated at 1 and 2 weeks of 
age, for which the same cutoff of pre-surgical lymphopenia was used. Inter-surgical 
lymphopenia was defined as average ALC (between 0.7 to 1.9 months) less than 2,500/mcl 
(below lower limit of 95% CI for patients 1 month old). The rationale for this approach was as 
follows: the ALC at 3 weeks (0.7m) was chosen to avoid the transient lymphopenia of the 
immediate first postoperative period.  ALC prior to 2 months of age was used to decrease any 
confounder factors associated with the second surgical period, because the infants from our 
cohort underwent the second palliative surgery (superior cavopumonary anastomosis or Glenn 
surgery) from 2.8 to 9.8 months. For the purpose of the data analysis, infants were 
dichotomized in 2 groups: 1) no documented ALC or normopenia versus 2) lymphopenia during 
the inter-surgical period.  Lymphopenia was defined using the ALC instead of T cell counts, 
given that the majority of patients did not have immune testing done and most of them were 
born prior the launch of severe combined immunodeficiency  (SCID) newborn screening (NBS)  
in Ohio.   
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Definition of Risk Factors The presence of chylous leak was identified by reviewing the 
discharge summaries in which 1) chylous leak were documented and 2) by reviewing nutrition 
orders in which diets used only in patients with chylous leak (Enfaport or Vivonex) were 
identified.  If the patient had any of these findings it was defined as having chylous leak between 
0.7 to 1.9 months.    
Prematurity and low birth weight were defined according the guidelines of the American 
Academy of Pediatricians: less than 37 weeks gestational age and less than 2.5 kg, 
respectively. 
The type of the first palliative surgery was defined as Norwood or Hybrid, and it was identified 
using discharge summaries and operative reports.  All patients with Norwood received 
30mg/kg/dose of methylprednisolone intraoperatively, compared to patients with Hybrid that did 
not receive intraoperative steroids. Infants receiving additional steroids doses (hydrocortisone) 
during 0.7-1.9 months of age were identified by reviewing the medication administered during 
that period of time.  
The type of thymectomy was defined as complete versus partial, reported in the operative 
notes.  If the patient had a partial thymectomy, it was annotated in the operative note.  Infants 
without documented partial thymectomy were defined as having complete thymectomy.  
In addition, absolute neutrophilic counts (ANC) between 0.7 to 1.9 months of age were 
evaluated to determine if infants had associated neutropenia, which could have contributed to 
poor postoperative outcomes.  
Definition of Outcome Measures  
Mortality within the first year of life (0.7-12m of age) was identified by reviewing the death notes, 
autopsy reports and death notifications notes.  Hospital length of stay after second surgery 
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(Glenn) was identified by reviewing the discharge summaries.  Longer hospital stay after Glenn 
was defined as more than 9 days (using the median as a cutoff). Post-operative infections 
(within 30 days of Norwood/Hybrid or Glenn) were identified by reviewing the discharge 
summaries (0.7-12 m of age). High number of postoperative infections was defined as 2 or more 
postoperative infections within the first year (0.7-1.9 months). Superior vena cava pressure was 
identified reviewing the reports from cardiac catheterization done in preparation for Glenn 
surgery.  Infants being placed in extracorporeal membrane oxygenation (ECMO), during the first 
year of life, were identified by reviewing the chart notes.  
Statistics 
Continuous descriptive variables were presented as median (min-max).  The presence of 
lymphopenia and descriptive characteristics were presented using percentages. Chi-square was 
used to compare the proportion of pre-surgical with inter-surgical lymphopenia. Multivariate 
logistic regression was used to compare risk factors and characteristics between the groups of 
infants with and without lymhopenia.  The differences in ALC, ANC and SVC pressure, 
according to deceased status or number of postoperative infections, were evaluated using 
Wilcoxon test. Survival probabilities of infants, according to lymphopenia status, were assessed 
using Kaplan Meier analysis. The survival difference, according to lymphopenia status, was 
analyzed using the log rank test. The association between lymphopenia and mortality, longer 
hospital stay or high number of postoperative infections was evaluated using multivariate logistic 
regression.  Associations were presented using odds ratio and 95% confidence intervals. The 
correlation between SVC and ACL was assessed using Pearson correlation test. The 
association between ECMO and inter-surgical lymphopenia was analyzed using Fisher test.  A p 
value of <0.05 was considered significant for all statistical analyses. Statistical analyses were 
performed using SAS 9.3 and R 3.0.1 software packages.  
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Results: 
Illustrative case 
We evaluated a patient born term with a prenatal diagnosis of HLHS who developed recurrent 
infections during the first 4 months of life, including gram negative sepsis, RSV pneumonia and 
Staphylococcus Aureus pneumonia. Laboratory testing revealed severe lymphopenia and 
neutrophilia, occurring after the first palliative surgery (Figure 1A).  More extensive immune 
testing revealed decreased CD4 Naïve Cells and hypogammaglobulinemia (Figure 1B). This 
was surprising, given a normal newborn screen for T cell lymphopenia and no evidence for 
chylous effusion. In vitro proliferation of T cells to mitogen was normal.  
Review of the medical history revealed several factors that may have contributed to 
lymphopenia. The infant underwent cardiac bypass with high dose steroid administration at the 
time of the Norwood (first palliative surgery, 10 days old) and Glenn (second palliative surgery, 
5 months old). The infant also had iatrogenic thymectomy with the first surgery; and presented 
with episodes of hypoxemia and hypotension, leading to the use of hydrocortisone for presumed 
adrenal insufficiency.  Given the history of recurrent infections, lymphopenia and 
hypogammaglobulinema, the infant was placed on weekly IVIG.   
There was evidence for ongoing cardiac compromise after the Norwood procedure. Cardiac 
catheterization done in preparation for Glenn procedure, showed a superior vena cava (SVC) 
pressure of 10 mmHg (higher than expected <8mmHg). At 5 months of age, right pulmonary 
artery reconstruction was performed, and cardiac catheterization showed 13 mmHg SVC 
pressure.  At 6 months of age, the infant re-developed hypoxemia and presented with SVC 
pressure of 22mgHg, and underwent re-stenting of the Blalock Taussing shunt.  However, 
continued with deterioration, progressing to multi-organ failure and death at 8 months of life. 
Although the primary problem appeared to be cardiac, it was difficult to distinguish whether the 
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infant’s compromised status was also related to lymphopenia and immune dysfunction. We 
searched the literature to determine if immune dysfunction had been described in other infants 
with HLHS. 
T Cell Lymphopenia in infants with HLHS 
Recent SCID newborn screening reports have identified infants with HLHS and abnormal 
TRECS [5-7]. We calculated the expected proportion of infants with TCL and HLHS to 
determine if infants with HLHS were over-represented. Using the HLHS birth frequencies 
(provided by each state, [8] ) and the number of births during NBS time period, we estimated the 
expected number of HLHS births (HLHSest, Supplementary table I). Then, we calculated an 
estimated rate of TCL in infants with and without HLHS using the data provided by the NBS 
reports. The calculated rate of TCL in infants with HLHS was 160 times higher than the 
calculated rate in infants without HLHS (p<0.001).   
Patient cohort 
Although TCL was reported more commonly in HLHS than expected in the general population, 
the reports did not indicate whether these infants were tested at birth or following surgery, as 
screening is commonly conducted at 24 hours and repeated in the first month of age if 
inconclusive. Therefore, we conducted a retrospective chart review of patients with HLHS at our 
own institution. A total of 203 patients with HLHS were evaluated between 2008-2014 
(Supplementary Figure 1). Seventy-seven patients had ALC reported during the first 4 months 
of life, and 68 met the inclusion criteria (Supplementary Fig 1).  Nine (9) patients were excluded 
due to:  delayed (>30 days) surgical correction/ thymectomy (6), other surgeries rather than 
Norwood or Hybrid (2), and absence of information about cardiac surgeries (1). Forty-four 
infants (67%) had inter-surgical ALCs between 0.7-1.9 months of life, whereas 22 (33%) infants 
had no available ALCs during that period of time (Figure 2). 
7 
 
Table I and Supplementary Table II show the descriptive characteristics of the cohort. Most of 
the infants were male (60%) and underwent Norwood (75%) for the first palliative surgery. Five 
patients underwent cardiac transplant, but the lymphocyte data of interest was prior to the date 
of transplant.  Most (88%) of the infants were term (38 weeks, 29-40 weeks) with normal birth 
weight (88%). Forty-four (65%) infants had genetic testing but none presented with genetic 
mutations known to be associated with immune dysfunction (22q11deletion, CHD7 mutation or 
Trisomy 21).   One infant was found with mosaic Turner and died before one month of age.  
Another infant was found with 4q28.3 deletion, which is associated with CHD and lymphopenia.  
However, this patient did not present with lymphopenia before or after surgery.  
Infants with lymphopenia prior to surgery: 
We first analyzed the proportion of infants presenting with lymphopenia prior to surgery, looking 
for the possibility of primary lymphopenia. Fifty three infants had ALCs documented prior to the 
first surgery and 3 (5.3%) of them had lymphopenia. None of these 3 infants had more 
extensive immune testing or NBS for TCL.  Their ALCs, during the first year, are plotted in 
Supplementary Figure 2. One patient had ALC normalization 2 weeks after the first surgery, but 
re-developed persistent lymphopenia at 3 years of age (before third surgery).  The second infant 
had ALC normalization prior to surgery, but re-developed persistent lymphopenia at 1 month, 
related to coincident chylous leak. This infant also developed recurrent infections: fungal UTI (2 
weeks post Norwood), aseptic meningitis (1month post-Norwood), multiple inter-surgical 
hospitalizations due to viral illness, acute otitis media and gram negative bacteremia (at time of 
death, 11 months).    ALCs from the third infant normalized at 5 days following Hybrid 
correction. After two episodes of bacterial tracheitis, the infant developed sudden cardiac 
deterioration and death at 4 months.   
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Infants with lymphopenia following first surgery: 
In contrast to pre-surgical lymphopenia, a significant number of infants developed lymphopenia 
following the first palliative surgery. Fifteen (34%) of the 44 infants with available ALC presented 
with lymphopenia in the inter-surgical period (between 0.7 to 1.9 months), compared to 5% of 
infants with lymphopenia before surgery (p <0.001).   Similarly, 35% (n=46) and 30% (n=37) of 
the infants presented with lymphopenia at 1 and 2 weeks of life, respectively.  The period of 
time between 3 weeks (0.7m) and 7 weeks (1.9m) of age was chosen: 1) first to avoid the 
immediate post-operative period of Norwood/Hybrid procedure and the operative period of the 
Glenn procedure (second palliative surgery) and 2) second to evaluate lymphopenia in a critical 
period of time in which these infants present with the highest mortality rate. We evaluated 
potential risk factors for developing lymphopenia following surgery using a multivariate 
regression model (Table II). As expected, infants with inter-surgical lymphopenia presented with 
a higher proportion of chylous leak (40%) as compared to infants without lymphopenia (3.4%).  
Chylous leak was associated with an increased risk for inter-surgical lymphopenia (OR= 18.9, 
CI 1.9-186.4, p=0.01). Otherwise, there were no significant differences between the group of 
patients with and without lymphopenia regarding type of thymectomy (complete versus partial) 
or type of first palliative surgery (Hybrid versus Norwood).   
Data about hydrocortisone stress doses was not included in the multivariate regression model 
given that there was missing information for 23 infants. For this reason, a univariate logistic 
regression was performed showing that infants receiving inter-surgical hydrocortisone (0.7-
1.9m) had an increased risk for inter-surgical lymphopenia (n= 30, OR=7.5, CI=1.2-45.2, 
p=0.03). Prematurity was also excluded in the multivariate regression analysis, given that 88% 
of the infants were term. However when the 4 premature infants were compared to infants born 
term (n=35), a higher proportion of premature patients presented with lymphopenia (75%) as 
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compared to term infants (26%), suggesting that prematurity may have represented an 
additional risk factor if more infants were available for analysis.       
Mortality: 
Having determined that inter-surgical lymphopenia was more prevalent than lymphopenia prior 
to surgery and that these infants with pre-surgical lymphopenia had ALC correction at some 
period of time, we then focused on the association of inter-surgical lymphopenia (0.7-1.9m) with 
poor postoperative outcomes.  We first analyzed the association between lymphopenia and 
mortality (0.7-12months). Twenty-one infants (31%) died within the first year of life, and the 
majority died before the second palliative surgery (Glenn procedure): 17/20, 85%. One infant did 
not have Glenn because of cardiac transplant. Only 6 patients had autopsy done. Pneumonia 
was the immediate cause of death for 2 of them, whereas the underlying cardiac disease was 
the cause of dead for the others.   
 
When the inter-surgical average ALC was compared between infants with and without death 
during the first year of life, it was apparent that infants who died during the first year of life 
presented with lower ALCs as compared to patients who survived (Figure 3A, p=0.02). The 
average ANC was also compared, showing that infants dying during the first year of life 
presented with higher ANC rather than neutropenia as compared to infants who survived 
(Figure 3A, p= 0.03). It is important to note that none of the infants presented with neutropenia.  
 
To further evaluate the relationship between lymphopenia and mortality, the infants were divided 
in 3 groups: 1) no documented ALC 2) normopenia or 3) lymphopenia during the inter-operative 
period. A Kaplan Meier curve was plotted, demonstrating that infants with no available ALC and 
normopenia have a higher survival probability compared to infants with lymphopenia (Figure 4, 
p=0.03).  After determining that inter-surgical lymphopenia is associated with mortality during 
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the first year, we performed a multivariate regression model looking for the risk of death in 
infants presenting with inter-surgical lymphopenia.  Infants were subdivided in 2 groups: 1) no 
documented ALC or normopenia versus 2) lymphopenia during the inter-surgical period.   Inter-
surgical lymphopenia, hybrid surgery, complete thymectomy and age at thymectomy were 
evaluated as possible risk factors for mortality (Table III). Lymphopenia (OR= 4.36, CI= 1.1-
17.0, p=0.03) and Hybrid procedure (OR= 7.57, CI = 1.9-29.5, p=0.004) were found to be 
associated with an increased risk for mortality during the first year of life. Complete thymectomy 
and younger thymectomy age were not associated with an increased risk for mortality. The 
association between chylous leak (0.7-1.9m) and mortality was independently analyzed (n= 65, 
OR = 4.2 CI= 0.8-21 p= 0.08), but it was non-significant. Similarly, the association between 
prematurity and mortality was non-significant (N= 55 OR= 1.54 CI 0.3-9.5 p=0.64). However, 
low birth weight was independently associated with an increased risk for mortality during the first 
year (N= 48 OR= 6.5 CI= 1.2-35.6 p=0.03), as expected. 
 
Hospital length of stay after second surgery:   
The second postoperative outcome was length of stay after the second palliative surgery 
(Glenn). A multivariate logistic regression model was used to analyze if inter-surgical 
lymphopenia, hybrid surgery, complete thymectomy and age at thymectomy were predictors for 
longer hospital length of stay after Glenn (>9 days). Hospital length of stay after first palliative 
surgery was not evaluated, given that some infants were discharged before the evaluated inter-
surgical ALC.  No factors were found as predictors for longer hospital stay (Table III), including 
inter-surgical lymphopenia (p= 0.23).  However, the sample size used for this data analysis was 
reduced, given the large proportion of patients who died prior to Glenn procedure.  
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Number of Postoperative Infections: 
The third postoperative outcome was the number of infections 30 days after surgery 
(Norwood/Hybrid and/or Glenn), between 0.7 and 12 months of life.  The ALC distribution 
according the number of postoperative infections showed that infants with 2 postoperative 
infections had lower ALC as compared to infants with 0-1 postoperative infections (Figure 3B, 
p=0.03). In contrast, when ANC was compared between these 2 groups, there were no 
significant differences (Figure 3B, p=0.18). For this reason, a multivariate logistic regression 
model was used to analyze if lymphopenia is a risk factor for a higher number of postoperative 
infections. Inter-surgical lymphopenia was categorized as: no documented ALC or normopenia 
versus lymphopenia.  Number of postoperative infections was categorized as: 2 postoperative 
infections versus 0-1 postoperative infections.   Lymphopenia was found to be associated with 
an increased risk for a higher number of postoperative infections (Table III, OR= 11.74, CI= 1.9-
71.0, p=0.01). None of the other factors were found to be associated with an increased number 
of postoperative infections.  However, the presence of 2 postoperative infections was not 
independently associated with mortality during the first year of life (N= 65, OR= 2.15, CI = 0.43-
10.64, p =0.40).  When the association of chylous leak was analyzed independently by Fisher t-
test, chylous leak (p=0.02) was found to be associated with a higher number of postoperative 
infections.  Supplementary Figure 3 shows the different etiologies for the postoperative 
infections, including wound infections, bacterial respiratory illnesses, urinary tract infections 
(UTI), necrotizing entercolitis (NEC) and bacteremia/sepsis. 
Immune Results in the Early Post-Surgery Period:  
Having determined that inter-surgical lymphopenia is common in infants with HLHS, we then 
review the charts of infants with more extensive immune testing. None of the immune testing 
was done prior to the first surgery and only data prior cardiac transplant was reviewed 
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(Supplementary Table III).  Further on, all available newborn screens for TCL were evaluated, 
which were done prior to first surgery (Table IV).  
The available immunoglobulin levels were also assessed.  Only 5 infants had IgG counts done 
at 0.7-1.9 months and 2 of them presented with low IgG.  Of the infants presenting with chylous 
leak (0.7-1.9m), 6/7 had documented immunoglobulins during the first year of life.  These 
records were evaluated in detail. Three infants presented with low IgG at the inter-surgical 
period (0.4-1.9m). All of them received IVIG (1gram/kg/dose). In particular, one of them was 
receiving weekly IVIG from 2 to 3 months of age, with an average rate of IgG loss of 
190mg/day. His IgG levels were decreasing below normal levels in approximate 3 days after 
receiving IVIG.   
Association of Lymphopenia with severity of illness  
Given that inter-surgical lymphopenia was found to be associated with mortality and 
postoperative infections during the first year of life, we then evaluated the association between 
lymphopenia and severity of illness. For this reason, extracorporeal membrane oxygenation 
(ECMO) during the first year of life was used as a surrogate marker for severe illness. In total, 
19 infants (28%) were placed in ECMO during the first year of life.  Using Fisher t-test, ECMO 
was find to be associated with mortality during the first year of life (p=0.02) and inter-surgical 
lymphopenia (p=0.004), but not with the number of postoperative infections (p=0.38).  This 
suggests an association between severity of illness and inter-surgical lymphopenia, using 
ECMO as a surrogate marker.  
Correlation between Absolute Lymphocyte Count and Superior Vena Cava Pressure 
Having established that lymphopenia was associated with poor post-operative outcomes and 
illness severity during the first year of life, we wondered if lymphopenia was related to poor 
cardiac function. Given that the thoracic duct drains into the superior vena cava, increased 
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venous pressure may impair the egression of the lymphocyte from the tissues into the 
peripheral blood which may lead to chylous leak.  Therefore, we analyzed the relationship 
between inter-surgical ALC (0.7-1.9 m) and superior vena cava (SVC) pressure prior to the 2nd 
palliative surgery (Figure 5A).  We noted an inverse correlation (R=-0.52) with a significant p 
value (0.01). It was noted that below the threshold for normal ALC of 2,500 lymphocyte 
cells/mcl, SVC pressure increases above normal levels (>8 mmHg).  We also compared SVC 
pressure with mortality and number of postoperative infections.  Infants deceased during the 
first year of life presented with higher SVC pressure as compared to infants who survived 
(Figure 5B, p=0.005).  Similarly, infants presenting with 2 postoperative infections presented 
with higher superior vena cava pressure as compared with infants with 0-1 postoperative 
infections (Figure 5B, p=0.04).  
Discussion: 
Infants with HLHS present with a higher proportion (34%) of inter-surgical lymphopenia as 
compared to lymphopenia prior to surgery (p= <0.001).  There is reported data about infants 
undergoing first palliative surgery with cardiac bypass, in which 32% presented with pre-surgical 
lymphopenia [9].  However, this study differed to ours in that infants up to 2 years of age and 
with different types of congenital heart defects were included. In addition, lymphopenia was 
defined as less than 3,000 cells/mcl for all subjects. Therefore, our study is the first report 
describing the proportion of lymphopenia in infants with HLHS.  And our data suggests that 
lymphopenia in infants with HLHS is mostly associated with secondary causes. There are 
several factors that further substantiate the fact that these infants present with secondary 
lymphopenia. First, the 5 documented newborn screening results (done before surgery) were 
within normal limits. Second, the infants presenting with pre-surgical lymphopenia had ALC 
normalization at some point. And finally, infants with HLHS undergo several iatrogenic 
procedures which may contribute to the development of lymphopenia.  
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Infants with HLHS present with underdevelopment of the aorta and left ventricle, for which they 
rely on the patent ductus arteriosus to provide systemic blood flow.  Given that the patent 
ductus arteriosus closes during the first week of life, these infants depend on prostaglandin until 
the first palliative surgery (Norwood or Hybrid) is performed within the first 2 weeks of life.  
Not every infant with HLHS is severely ill. Infants that are stable, usually undergo Norwood 
procedure in which the aorta is reconstructed and connected to the right ventricle. During this 
procedure the pulmonary artery is also connected to the subclavian artery (Blalock taussing 
shunt) or to the right ventricle (Sano modification).  Infants undergoing Norwood are given 
intraoperative methylprednisolone (30 mg/kg/dose is typically used in our institution) to 
counteract the inflammatory response that occurs with cardiopulmonary bypass.  In contrast, 
infants that are severely ill undergo Hybrid procedure, which does not typically involve cardiac 
bypass. Hybrid procedure consists of pulmonary arteries banding and ductus arteriosus 
stenting.  During both surgeries, the thymus is typically removed to access the heart and great 
vessels, in order to perform the extensive aortic arch or the banding of the pulmonary arteries.  
This has been shown to negatively impact T cell maturation leading to decreased T cell counts 
during the first year of life [10-12]. If the infant survives, Glenn procedure is performed at 3-4 
months of age.  This procedure consists of the connection of the SVC to the pulmonary artery, 
in order to decrease the workload of the right side of the heart.  Finally, patients undergo Fontan 
procedure at 3-4 years of age, in which the inferior vena cava is connected to the pulmonary 
arteries.   
In addition to receiving methylprednisolone intraoperatively, these infants may receive 
hydrocortisone stress dosing in the inter-surgical period due to suspected adrenal insufficiency.  
In addition, these infants may develop chylous leak after surgery, which is associated with 
lymphopenia and hypogammaglobulinemia, as well. Chylous leak is associated with the 
increased systemic venous pressure that these infants present, for which lymphatic fluid return 
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may be impeded, leading to lymphocyte and immunoglobulin loss.   However, chylous leak may 
be also the result of thoracic duct injury during cardiac surgeries [13, 14].   
Although it is rare, patients with HLHS may present with primary immune defects. For example, 
HLHS is one of the heart defects that have been identified in Jacobsen Syndrome, which 
include both cardiac and T cell defects.  Despite HLHS being a rare cardiac defect (3% of births 
with CHD), it is found in 5% of patients with Jacobsen syndrome [15]. The candidate gene for 
Jacobsen syndrome is ETS-1 gene [16] and mice models have demonstrated a potential neural 
crest cell dysfunction for this syndrome. Reported data revealed the presence of ETS-1 gene in 
both heart endocardium and neural crest cells [16], which suggests a possible link between 
heart and thymus defects in Jacobsen Syndrome. However, our results suggest that primary 
lymphopenia in infants with HLHS is less common than secondary lymphopenia, and several 
risk factors for acquired lymphopenia were identified in our retrospective cohort.   
In our study, chylous leak (p=0.01) and hydrocortisone stress dose (p=0.03) were identified as 
risk factors for inter-surgical lymphopenia.  The association between lymphopenia and chylous 
leak can be further substantiated by the fact that infants presenting with higher SVC pressures 
presented with lower ALCs (p=0.01), who at the same time may have chylous leak due to 
increased venous pressure. The relationship between hydrocortisone and lymphopenia is 
explained by previous reports in which patients receiving steroid treatment presented with 
lymphopenia [17, 18].  Similar to our study, Cabrera study demonstrated that infants with CHD 
and pre-surgical lymphopenia presented with a higher proportion of post-operative 
hydrocortisone use (p=0.009) and chylous effusions (p=0.002) [9]. However, as mentioned 
previously, this study evaluated different types of cardiac defects and included patients up to 2 
years of age.  
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The impact of early thymectomy could not be evaluated in our study, given that all of the infants 
underwent thymectomy within the first month of life.  However, we evaluated the impact of total 
versus partial thymectomy given that previous data reported that patients with complete 
thymectomy have decreased T cells during the first 3 years of life as compared to patients with 
partial or no thymectomy (p <0.05)[12]. Another study showed that low naïve T cells in patients 
with CHD (mean age= 19 y) was associated with no residual thymus [10]. However, in our 
study, the presence of complete thymectomy did not predict the development of inter-surgical 
lymphopenia.  Nevertheless, the possibility of having residual or extra thymic tissue must be 
considered in patients with complete thymectomy. In addition, we did not have documented T 
cell counts for all the subjects, making difficult to examine the presence of decreased T cells in 
infants with complete thymectomy. Further on, the impact of prematurity and low birth weight 
could not be evaluated given that most of the infants (88%) were born term and with normal 
weight. However, prematurity is expected to be associated with lower lymphocyte counts [19], 
and must be considered in infants presenting with lymphopenia.  
One of the significances in evaluating the presence of lymphopenia in infants with HLHS, is 
having determined that it is associated with mortality. Infants with HLHS have a high mortality 
rate during the first year of life (about 32-49%) [1-4]. Similarly, our study demonstrated that 
approximately one third of the infants (31%) died during the first year of life.  Importantly, most 
of these infants died before Glenn surgery (85%), demonstrating that this is a critical period of 
time. For this reason, we focused in this period of time, looking for adverse poor outcomes 
associated with inter-surgical lymphopenia.  
Inter-surgical lymphopenia was found to be associated with an increased risk for adverse 
postoperative outcomes. First, it was found to be associated with an increased risk for mortality 
(OR= 4.36, CI=1.1-17.0), as well as hybrid procedure (OR= 7.57, CI=1.9-29.5).    It is important 
to note that infants with lymphopenia presented with lower survival probabilities as compared to 
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infants with no documented ALC or normopenia. This leads to the fact that special attention 
should be placed in the lymphocytes counts for infants with HLHS undergoing laboratory 
evaluation during the inter-surgical period. 
 
Similar to our study, Cabrera data have shown that patients with CHD and lymphopenia prior to 
first cardiac surgery presented with an increased risk for postoperative hospital mortality (OR= 
15.9 CI=3.5-72, p=0.001) and potential increased risk for infections using number of cultures 
sent as surrogate marker (OR 1.02, CI 1-1.03, p=0.01)[9]. In our study, lymphopenia was also 
found to be a predictor for a higher number of postoperative infections (OR=11.74, CI=1.9-71.0). 
Another study further substantiates the potential association between lymphopenia (in the 
setting of postoperative steroids) and postoperative infections.  This study showed that 
prolonged postoperative steroids (5-12  versus 2-5 days) in pediatric patients (up to 5 years of 
age) undergoing complex cardiac surgeries was associated with an increased rate of 
postoperative infections (p<0.001) [20]. It is unknown if these infants were also presenting with 
lymphopenia. However, as we described earlier, infants receiving post-operative steroids may 
present with lymphopenia as well.  Nevertheless, the association between post-operative 
infections and mortality is unclear, given that most of the infants in our study did not have 
autopsy. However, 2/6 documented autopsies had pneumonia as the immediate cause of death. 
Similarly, another study evaluating mortality after discharge of first surgery in infants with single 
ventricle anatomy demonstrated that 13% of the infants had pneumonia as the immediate cause 
of death [21].  
Regarding the type of infections, it is notable that most of these were of bacterial etiology: 
wound infection, bacterial respiratory cultures, urinary tract infections (UTI), necrotizing 
enterocolitis (NEC), sepsis and bacteremia. Similarly, one case report described an infant 
developing chylothorax and lymphopenia (948 cells/mm3) after esophageal repair, who 
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developed wound infection by Staphylococcus Aureus [22]. In another study, infants with CHD, 
chylothorax and lymphopenia were more likely to have bloodstream infections compared to 
patients without chylothorax [14]. Likewise, the main infections were: bloodstream infections, 
respiratory infections and UTI, in addition to infected pleural fluid [14]. Similarly, another study 
described infants with CHD, complete thymectomy and  decreased T cells presenting  with an 
increased number of respiratory infection related hospitalizations [12].  However, none of them 
were admitted to the intensive care unit and did not present with severe infections (sepsis, 
mediastinitis) [12], in contrast to our study in which several infants presented with severe 
infections. In contrast, another study evaluating T cell counts during the first year of life, 
described infants with CHD, early thymectomy (<30 days) and decreased T cells presenting 
with no increased infections as compared to the healthy controls [11].  
Interestingly, despite most of the infections being of bacterial etiology, none of the infants 
presented with neutropenia.  Although infants with chylous leak may present with 
hypogammaglobulinemia, which could result in UTI and respiratory infections [23], this does not 
explain the presence of infections associated with innate deficiency (NEC, wound infections, 
sepsis). TH-17 deficiency associated with lymphopenia is a potential cause for these innate 
infections. This is substantiated by the fact that patients with Hyper IgE syndrome, which has 
absence of IL-17 production by the TH17 cells, present with extracellular bacterial infections 
such as respiratory infections and staphylococcal abscesses [24].   In addition, murine models 
with TH17 deficiency present with a defect of clearance of uropathogenic E coli [25] and with 
larger skin lesions and higher bacterial counts after being inoculated with Staphylococcus 
aureus as compared to the wild type[26]. For this reason, it is possible that infants with HLHS 
may have been presenting TH17 deficiency in the setting of lymphopenia. Further prospective 
studies should evaluate the presence of TH17 deficiency in these infants.  
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It is evident that lymphopenia is associated with both increased risk of mortality and 
postoperative infections. Nevertheless, it is unclear whether it leads to an increased risk of 
death or it is only a marker of severe cardiac illness.  Our study substantiates that lymphopenia 
is a marker of illness severity, given that we discovered an inverse correlation between ALC and 
SVC pressure, and that infants being placed in ECMO presented with an increased proportion 
of inter-surgical lymphopenia.  These results suggest that lymphopenia in infants with HLHS 
may be associated with severity of illness, and not directly with mortality.  
Having determined that infants with inter-surgical lymphopenia presented with an increased rate 
of mortality and postoperative infections during the first year of life, prophylactic therapy should 
be considered.  However, there are no current guidelines for the management of inter-surgical 
lymphopenia in infants with HLHS.  Given the increased rate of postoperative infections 
associated with lymphopenia, infection control measures such as contact isolation should be 
considered as prophylaxis.  In infants with inter-surgical lymphopenia and no evidence of 
chylous effusions, IVIG prophylaxis during the inter-surgical period may be also considered.  But 
further prospective studies are needed to evaluate the effectiveness of this approach. In 
contrary, there is data about IVIG treatment in patients with CHD and chylous leak, but it is 
controversial.  In a retrospective study of infants with CHD presenting with chylous leak and 
lymphopenia, IVIG treatment was not associated with decreased infections or increased survival 
[14].  Moreover, this could be related to selection bias because the infants receiving IVIG had 
more complex and severe cardiac disease; which could underestimate the effects of IVIG 
replacement. For this reason, the use of IVIG for patients with HLHS should not be completely 
discarded and further prospective studies should be done.  
Indeed, prospective studies should be undergone to further evaluate lymphopenia as a marker 
for adverse postoperative outcomes, the potential association of TH-17 defects with 
postoperative infections and the effectiveness of prophylactic interventions. This study presents 
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with several limitations, mostly associated with its retrospective nature. One of the main 
limitations is that the majority of infants did not have immune testing.  In addition, all the 
documented immune testing was done after first surgery, making difficult to entirely rule out the 
presence of primary immunodeficiency.  Having a small sample size is another limitation. In 
addition, some of the data was missing from the records, such as laboratory testing, which may 
lead to information bias.   However, the ultimate goal of this project is to obtain preliminary data 
for future prospective cohort studies in which information bias will be minimized.  Moreover, this 
is the first study done in infants with HLHS evaluating the proportion of lymphopenia and its 
clinical impact, which is the most important significance of this study.   
Conclusion 
Inter-surgical lymphopenia is common in infants with HLHS, which is associated with an 
increased risk for mortality and postoperative infections during the first year of life.  It is unclear 
if lymphopenia directly contributes to mortality.  For this reason, further prospective cohort 
studies should be done to evaluate the causal relation between lymphopenia and mortality.  
However, the association of low ALC with higher SVC pressure and with ECMO, suggest that 
lymphopenia is a marker of illness severity rather than a direct cause of mortality. For this 
reason, persistent inter-surgical lymphopenia in infants with HLHS should raise a suspicion for 
severe cardiac illness.  
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Table I. Baseline Characteristics of Infants with HLHS: Categorical Data 
Characteristics 
Infants, n=68 
no. (%) 
Gender  
Male 41 (60.3) 
Female  27 (39.7) 
Type of First Surgery   
Hybrid 17 (25) 
Norwood 51 (75) 
Complete Thymectomy   
Yes 55 (80.9) 
No 13 (19.1) 
Cardiac Transplant   
Yes 5 (7.4) 
No 63 (92.6) 
HLHS Type   
Mitral Stenosis/Aortic Stenosis 13 (19.2) 
Mitral Stenosis/ Aortic Atresia 16 (23.5) 
Mitral Atresia/ Aortic Atresia 27 (39.7) 
Mitral Atresia/ Aortic Stenosis 2 (2.9) 
Mitral Hypoplasia/ Aortic Atresia 1 (1.4) 
Mitral Hypoplasia/ Aortic Hypoplasia 5 (7.4) 
Mitral Hypoplasia/ Aortic Stenosis 1 (1.5) 
Subaortic VSD/ Mitral Hypoplasia 1 (1.5) 
Shone Complex (VSD, Mitral Hypoplasia, Aortic Hypoplasia) 2 (2.9) 
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Table II. Risk factors for Inter-surgical Lymphopenia  
Risk Factor Lymphopenia, n=15 
no. (%) 
Normopenic, n=29 
no. (%) 
OR (95% CI) P value 
Hybrid Surgery 5 (33.3) 9 (31.0) 0.86 (0.2-4.1) 0.85 
Complete Thymectomy 12 (80.0) 25 (86.2) 0.95 (0.1-6.8) 0.96 
Chylous Leak  6 (40.0) 1 (3.4) 18.94 (1.9-186.4) 0.01* 
*P <0.05 after multivariate logistic regression analysis. 
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Table III. Risk factors for Mortality, Postoperative Infections and Prolonged Hospital Stay after Glenn 
 Mortality, 
n=66 
Postoperative Infections†,  
n=66 
Prolonged Hospital Stay 
after Glenn, n= 40 
Risk Factor OR (95% CI) 
P 
value OR (95% CI) P value OR (95% CI) P value 
Hybrid Surgery 7.57 (1.9-29.5) 0.004** 0.88 (0.1-6.7) 0.90 7.39 (0.7-75.1) 0.09 
Inter-surgical Lymphopenia 
†† 
4.36 (1.1-17.0) 0.03* 11.74 (1.9-71.0) 0.01* 3.22 (0.5-21.7) 0.23 
Complete Thymectomy 2.72 (0.5-15.8) 0.26 1.91 (0.2- 23.5) 0.61 0.88(0.2-4.4) 0.87 
Thymectomy Age  1.02 (0.9-1.2) 0.77 1.05 (0.9-1.3) 0.56 1.04(0.9-1.3) 0.70 
*P <0.05 after multivariate logistic regression analysis. 
**P <0.01 after multivariate logistic regression analysis. 
†
 Infants with 2 postoperative infections were compared to infants with 0-1 postoperative infections.  
†† 
Infants with inter-surgical lymphopenia were compared to infants with no ALC or with normopenia between 0.7-1.9 
months of life.  
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Table IV. ALC from Infants with available TREC Results  
 TREC 
(Newborn) 
ALC Prior 
Surgery    (K 
cells/mcl) 
ALC:  1 week 
Post-Surgery 
(K cells /mcl) 
ALC: 8 week 
Post-Surgery 
(K cells /mcl) 
CD4 CD45 RA(%),            
1 month of age 
Deceased 
(Age in months) 
200 
 
Normal None 5.62 4.86 None No 
201 Normal 2.82 1.67  1.12  40.2 (82-89.9) Yes (8.1m) 
202 
 
Normal 8.1 7.1 None None No 
204 
 
Normal 3.92 5.92 None None Yes  (3 m) 
205 
 
Normal 3.29 3.19 None None No 
Abnormal Values are marked in bold.  
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FIG 1. Immune laboratory results and absolute lymphocyte counts (ALC) of an infant with hypoplastic left heart 
syndrome (HLHS) and recurrent infections. A, The infant presented with normal ALC when newborn, but developed 
persistent lymphopenia after first palliative surgery (Norwood). B, The infant presented with severe T cell 
lymphopenia, decreased Naïve T cells, hypogammaglobulinemia, but normal T cell function, after Glenn (second 
palliative surgery).  
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FIG 2. Cohort of infants with hypoplastic left heart syndrome (HLHS) evaluated for lymphopenia during the inter-
operative period (0.7-1.9 months).  The cohort is subdivided in patients who 1) died before 3 weeks (0.7months), 2) 
had absolute lymphocyte counts (ALC) or 3) did not have ALC during the inter-surgical period. Most of the infants 
without documented inter-surgical ALC, survived the first year of life (86%) compared with the infants for which ALC 
was done at 1 month of life (64%). Of the deceased infants with inter-surgical ALC, half of them were lymphopenic 
compared to the infants who survived during the first year of life (25%).  
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FIG 3. Lymphopenia, but not neutropenia, is associated with mortality and post-operative infections. Using Wilcoxon 
sum rank test, ALC and ANC (during the inter-operative period) were compared, according to deceased status and 
number of post-operative infections.  A, Infants who died (between 0.7-12m) presented with lower ALC as compared 
to infants who survived.  However, infants who died presented with higher ANC as compared to infants who survived. 
B, Infants with 2 post-operative infections presented with lower ALC as compared to infants with 0-1 postoperative 
infection. However, there was no significant difference in the ANC of infants with 2 postoperative infections as 
compared to infants with 0-1 postoperative infections. Data is expressed as medians with interquartile range. *P 
<0.05 after analysis with the Wilcoxon sum rank test.  
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FIG 4. Survival of infants according to lymphopenia status. Patients were classified in three groups: 1) No 
documented absolute lymphocyte count (ALC) 2) Normopenia or 3) Lymphopenia during the inter-operative period. 
Infants with lymphopenia presented with a lower survival probability as compared with infants without ordered ALC or 
normopenia. Data is expressed as proportions. *P <0.05 after the Kaplan-Meier analysis.   
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FIG 5. Association of poor cardiac function with low ALC, mortality and postoperative infections. A, The average 
absolute lymphocyte count (ALC) was compared to a measure of cardiac function, the SVC pressure recorded at 
cardiac catheterizations prior to the second surgery (Glenn) for 35 patients.  The ALC and superior vena cava (SVC) 
pressure were inversely correlated, suggesting that the ALC is related to poor cardiac function rather than a primary 
immune problem.  The association is expressed as Pearson correlation coefficient (r). *P <0.05 after the analysis of 
the covariance. The dashed line indicates the lower limit of normal for ALC at 1 month of age. The normal values for 
SVC are less than 8 mmHg in healthy infants. B, Increased SVC pressure is associated with mortality within the first 
year of life.  Superior vena cava (SVC) pressure was compared according to deceased status and number of 
postoperative infections.  Deceased infants presented with higher SVC pressure as compared to infants who survived 
during the first year of life.  Infants with 2 postoperative infections presented with higher SVC pressure as compared 
to infants that had 0-1 postoperative infections. Data is expressed as medians with interquartile range. *P <0.05 and 
**P <0.01 after analysis with the Wilcoxon sum rank test.  
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Grey shading highlights data from NBS reports. HLHSest is calculated based on the birth rates with HLHS reported by 
national birth defects preventive network (NBDPN) [8] and the total number of  births during the newborn screening. 
TCLHLHS+  indicates the number or percentage of infants with HLHS identified with TCL. TCL HLHS- indicates the 
number or percentage of infants without HLHS identified with TCL.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table I. Calculated rate of TCL in infants with and without HLHS 
State Total 
Births 
Reported 
HLHS per 
10,000 
live births 
HLHSest Actual 
TCLHLHS+ 
Actual 
TCLHLHS- 
Estimated 
%TCLHLHS+ 
Estimated 
%TCLHLHS- 
P value  
(TCLHLHS+ 
vs TCLHLHS-) 
WI[5] 207,696 1.6 (33) 1 32 (3.0%) (0.015%)  
CA[7] 993,724 2.8 (278) 3 47 (1.1%) (0.005%)  
NY[6] 485,912 2.46 (120) 3 94 (2.5%) (0.02%)  
All 1,687,332  (431) 7 173 (1.6%) (0.01%) <0.001 
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Supplementary Table II.  Baseline Characteristics of Infants with HLHS: Numerical 
Data 
Characteristic n median (min-max) 
Week of Gestational Age 57 38 (29- 40) 
Birth Weight (kg)  49  3.2 (1.8-4.4) 
ALC Pre Surgery (K cells/mcl) 53 3.69 (1.36-10.4) 
Average ALC Post Surgery (K cells/mcl) 44 2.95 (0.57-7.4) 
Average ANC Post Surgery (K cells/mcl) 44 4.98 (2.35-14.49) 
Age Norwood/Hybrid (days) 68 5 (0-25) 
Age Glenn (months) 45 4.7 (2.8-9.8) 
Age at Cardiac Transplant (months) 5 3.5 (2.5-9.6) 
Length of Post-Op Stay for Norwood/Hybrid (days) 52 26.5 (9-160) 
Length of Post-Op Stay for Glenn (days) 40 9 (2-109) 
Superior Vena Cava Pressure (mmHg) 35 7.00 (3-14) 
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Abnormal Values are marked in bold.  
 
 
 
 
 
 
 
 
 
Supplementary Table III. Immune Results in the Early Inter-surgical Period 
Subject Age  CD4+    
T cells 
(Ref) 
CD8+   
T cells 
(Ref) 
%CD4 
Naïve  
T cells 
(Ref) 
%CD8  
Naïve    
T cells 
(Ref) 
IgG 
levels 
(Ref) 
Vaccine  
response 
Mitogens 
(Ref) 
Rationale for 
Immune 
Evaluation 
171 
Norwood 
(25 d) 
5 mo 
(1m Post 
Glenn)  
1144- 
1723 
(1400-
5100) 
 
219-450 
(600-
2200) 
 
80  
(82-90) 
74.1 
(77.7-
98.4) 
166, 
then 
460 
(250-
1190) 
 PHA: 138,215 
(>135,190) 
Con A:170,003 
(>75,240) 
Chylous leak at 
2 months of age 
 
Severe 
infections (2-4 
m.):  Sepsis, 
NEC, AOM 
 
Survived 
1.5 yr 
(Pre Fontan) 
1473 
(900-
5500) 
539 
(400-
2300) 
   Tetanus 
titer: 2.3 
Pneumoco-
ccus titers: 
12 >1.5 
 
196 
Norwood 
(7d) 
2 mo (2m post 
Norwood and   
Before Glenn)  
1333  
(1500-
5000) 
 
413  
(500-
1600) 
 
  162 
(141-
930) 
  Severe 
infections during 
1
st
 month: NEC, 
omphalitis 
 
Chylous leak at 
1yr, IVIG 
replacement 
since 16m.o.; 
Died 17m.o. 
1yo ( 6 m 
post Glenn) 
    246-843 
(400-
1250) 
 
Tetanus 
titer: 1.0 
Pneumoco-
ccus titers: 
12 >1.5 
PHA: 80,741  
(>135,190) 
Con A: 40,444  
(>75,240) 
198- 
Norwood 
(10 days) 
 
Cardiac 
Transplant 
(3.8m) 
2.8 m (2 
months after 
Norwood and 
before Cardiac 
Transplant) 
 
1315  
(1500-
5000) 
 
381 
(500-
1600) 
 
     Severe 
infections (0-
3m): Sepsis, 
Sternal Wound 
Infection, 
Bacteremia;  
Survived 
201  
Norwood 
(10 days) 
5.3 mo (same 
day of Glenn) 
106  
(1400-
5100) 
 
45  
(600-
2200) 
 
  102-657 
(250-
1190) 
 
 PHA: 143,423 
(>135,190) 
Con A: 97,342 
(>75,240) 
Severe 
Infections 
during first 4 
months: Sepsis, 
pneumonia  
 
IVIG 
replacement at 
1m.o. and 5-
8m.o.; 
Died at 8m.o. 
6 mo (3 weeks 
post Glenn)  
74  
(1400-
5100) 
 
33  
(600-
2200) 
 
40 
(82-
89.9) 
95.4 
(71.1-
100) 
248-560 
(250- 
1190) 
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Supplementary FIG 1. Cohort of patients with Hypoplastic Left Heart Syndrome (HLHS) evaluated at CCHMC 
(Cincinnati Children’s Hospital Medical Center) between January 2008 and August 2014. From a total of 203 subjects 
with HLHS, only 68 subjects met the inclusion criteria.  
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Supplementary FIG 2. Outcome of Infants with pre-surgical lymphopenia. Three infants presented with lymphopenia 
before first surgery. Evaluation of ALC over the first year of life showed that it corrected within the first month of life 
for all of them.  However, subject 114 had recurrence of lymphopenia associated with chylous effusions.  
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Supplementary FIG 3. Etiology of Postoperative Infections.  Using retrospective chart review, the post-operative 
infections (post Norwood/Hybrid and/or Glenn) were documented for 16 infants with HLHS.  Bacterial respiratory 
infections include pneumonia and positive tracheal cultures. Fungus was found to be the causative agent for one of 
urinary tract infections.  
 
 
